Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novo Nordisk A/S    NOVO B   DK0060534915

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
Latest news on NOVO NORDISK A/S
04/24 NOVO NORDISK A/S : - Reduction of the share capital
04/24 NOVO NORDISK A/S : - Share repurchase programme
04/22 NOVO NORDISK A/S : Leo Club, Novo Nordisk help intellectually challenged kids
04/21 XOMA CORPORATION (NASDAQ : XOMA) Files An 8-K Termination of a Material Definiti..
04/21 NOVO NORDISK A/S : - Reduction of the share capital
04/20 NOVOZYMES A/S : Researchers Submit Patent Application, "Subtilase Variants", for..
04/20 NOVO NORDISK A/S : Patent Issued for Automatic Injection Device with a Top Relea..
04/20 NOVO NORDISK A/S : Researchers from Novo Nordisk Discuss Findings in Proinsulin ..
04/20 FINDINGS FROM NOVO NORDISK YIELDS NE : Pharmacokinetic and...
04/18 NOVO NORDISK A/S (ADR)(NYSE : NVO) Recognizes The Hemophilia Community
04/14 NOVO NORDISK A/S : introduces new web-based portal that helps patients track the..
04/12 NOVO NORDISK A/S : The Ambassador speaks at the launch of Novo Nordisk programme..
04/12 Denmark's Novo A/S ups Synlab stake to 20 percent before possible IPO
04/12 NOVO NORDISK A/S : The Ambassador speaks at the launch of Novo Nordisk programme..
04/12 Just Three of World's Top 28 Pharmaceutical Corporations Agree to Match Pledg..
04/10 NOVO NORDISK A/S : - Share repurchase programme
04/08 NOVO NORDISK A/S : Pharmatech to Attend World Vaccine Congress
04/05 NOVO NORDISK A/S : MorphoSys Nominates New Candidate for Supervisory Board
04/03 NOVO NORDISK A/S : Status regarding Novo Nordisk's holding of its own shares (31..
04/03 NOVO NORDISK A/S : - Share repurchase programme
03/31 NOVO NORDISK A/S : FDA posts briefing materials prior to Advisory Committee meet..
03/30 NOVO NORDISK A/S : New Findings from Novo Nordisk Update Understanding of Athero..
03/29 NOVO NORDISK A/S : resubmits new drug application for fast-acting insulin aspart..
03/29 NOVO NORDISK A/S : resubmits new drug application for fast-acting insulin aspart..
03/29 British business navigates rocky path to Brexit
03/29 ConvaTec's majority investors raise $1.2 billion via stake sale
03/28 UPDATE : Nordic, Avista To Sell 20% Stake In ConvaTec To Novo (ALLISS)
03/28 Nordic, Avista To Sell 20% Stake In ConvaTec, Further 15% In Placing (ALLISS)
03/27 NOVO NORDISK A/S : receives positive opinion from the European regulatory author..
03/27 NOVO NORDISK A/S : CHMP provides positive opinion for EU label update for Novo N..
03/27 NOVO NORDISK A/S : - Share repurchase programme
03/27 NOVO NORDISK A/S : Fiasp®, a new, ultra-fast acting mealtime insulin is availabl..
03/27 NOVO NORDISK A/S : New fast-acting mealtime insulin, Fiasp®, now approved and av..
03/27 NOVO NORDISK : Fiasp®, a new, ultra-fast acting mealtime insulin is available fo..
03/27 NOVO NORDISK A/S : Fiasp, New, Ultra-Fast Acting Mealtime Insulin Is Available f..
03/25 KELLER ROHRBACK L.L.P. : Files Class-Action Lawsuit Over the Inflated Price of I..
03/24 DONG Energy - Residues from Novo Nordisk and Novozymes to be converted into b..
03/24 NOVO NORDISK A/S : EMA panel backs Novo Nordisk's haemophilia B drug
03/24 NOVO NORDISK A/S : receives positive opinion from the European regulatory author..
03/24 NOVO NORDISK A/S : CHMP provides positive opinion for EU label update for Novo N..
03/24 NOVO NORDISK A/S : ex-dividend day for final dividend
03/23 NOVO NORDISK A/S : New Proinsulin Study Findings Reported from Novo Nordisk [Tot..
03/23 NOVO NORDISK A/S : Smithers Rapra's Extractables & Leachables USA 2017 program f..
03/23 NOVO NORDISK A/S : Resolutions from the Annual General Meeting of Novo Nordisk A..
03/20 NOVO NORDISK A/S : - Share repurchase programme
03/17 Special Purpose Needles Market 2017 - Cook Medical, MEDTRONIC, Smith's Medica..
03/17 CVS : Driving Affordable Solutions: Reduced Rx Prescription Savings Program
03/16 MARCH 13 DEADLINE ALERT : Law Offices of Howard G. Smith Reminds Novo Nordisk A/..
03/16 NOVO NORDISK A/S : Named on the FORTUNE 100 Best Companies to Work For® List for..
03/14 NOVO NORDISK A/S : New economic data finds Novo Nordisk's insulin degludec most ..
03/13 NOVO NORDISK A/S : - Share repurchase programme
03/11 Goldberg Law PC Announces Securities Class Action Lawsuit against Novo Nordis..
03/11 NOVO NORDISK A/S : Team Novo Nordisk Targets Tour of California As Race of the Y..
03/11 NOVO NORDISK 72 HOUR DEADLINE ALERT : APPROXIMATELY 72 HOURS REMAIN; FORMER LOUI..
03/11 NOVO NORDISK A/S : Pomerantz Law Firm Reminds Shareholders with Losses on their ..
03/09 NOVO NORDISK A/S : New Obesity Study Findings Have Been Reported by Researchers ..
03/09 NOVO NORDISK A/S : Study Data from Novo Nordisk Update Knowledge of Laboratory H..
03/09 NOVO NORDISK A/S : UTHealth receives $2.4 million grant to drive action-oriented..
03/09 MARCH 13 DEADLINE ALERT : Law Offices of Howard G. Smith Reminds Novo Nordisk A/..
03/09 NOVO NORDISK A/S : DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds I..
03/09 NOVO NORDISK A/S : The 81,508 Shares in Novo Nordisk a/S Acquired by Freestone C..
03/09 NOVO NORDISK A/S : begins bid for Global Blood Therapeutics
03/07 NOVO NORDISK A/S : Lawsuit for Investors in Novo Nordisk A/S (ADR) (NYSE:NVO) Sh..
03/06 NOVO NORDISK A/S : - Share repurchase programme
03/05 NOVO NORDISK A/S : Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses..
03/03 Levi & Korsinsky, LLP Reminds Shareholders of Novo Nordisk A/S of a Class Act..
03/02 NOVO NORDISK A/S : Lebanese Pediatric Endocrinology Club, Novo Nordisk call for ..
03/02 INVESTOR ALERT : GPM Reminds Investors of the March 13 Deadline in the Class Act..
03/02 NOVO NORDISK A/S : DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds I..
03/02 NOVO NORDISK A/S : Change in Novo Nordisk Executive Management
03/02 NOVO NORDISK A/S : UTHealth Receives $2.4 Million Grant to Drive Action-Oriented..
03/01 NOVO NORDISK A/S : &Aelig;ndring i Novo Nordisks koncerndirektion
03/01 NOVO NORDISK A/S : Change in Novo Nordisk Executive Management
02/28 NVO INVESTORS ALERT : Lieff Cabraser Reminds Investors of Deadline in Class Acti..
02/28 NOVO NORDISK A/S : files for regulatory approval of once-weekly semaglutide for ..
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Financials ( DKK)
Sales 2017 116 165 M
EBIT 2017 49 975 M
Net income 2017 37 856 M
Finance 2017 15 549 M
Yield 2017 3,03%
P/E ratio 2017 16,36
P/E ratio 2018 14,69
EV / Sales 2017 4,20x
EV / Sales 2018 4,00x
Capitalization 503 141 M
More Financials
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO B | DK0060534915 | 4-Traders
Full-screen chart
Technical analysis trends NOVO NORDISK A/S
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 32
Average target price 270  DKK
Spread / Average Target 7,9%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Lars Fruergaard Jørgensen President & Chief Executive Officer
Göran Albert Ando Chairman
Jesper Brandgaard Chief Financial Officer & Executive Vice President
Mads Krogsgaard Thomsen Chief Science Officer & Executive Vice President
Mads Krogsgaard Chief Science Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
NOVO NORDISK A/S-1.96%73 527
JOHNSON & JOHNSON6.67%333 142
ROCHE HOLDING LTD.8.21%220 797
PFIZER INC.3.88%200 926
NOVARTIS AG-1.08%195 490
MERCK & CO., INC.5.55%170 359
More Results